Shopping Cart
Remove All
Your shopping cart is currently empty
Aflibercept is a recombinant fusion protein antibody composed of the Ig domains of VEGFR1 and VEGFR2 and the Fc domain of human IgG1. Aflibercept inhibits VEGF signaling and is a commonly used tool in biological research for suppressing pathological angiogenesis.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 500 μg | $438 | - | In Stock | |
| 1 mg | $689 | - | In Stock |
| Description | Aflibercept is a recombinant fusion protein antibody composed of the Ig domains of VEGFR1 and VEGFR2 and the Fc domain of human IgG1. Aflibercept inhibits VEGF signaling and is a commonly used tool in biological research for suppressing pathological angiogenesis. |
| Synonyms | VEGF-TRAPR1R2, VEGF-trapR1, VEGF Trap, Aflibercept (VEGF Trap) |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Target | VEGF |
| Cas No. | 862111-32-8 |
| Storage | Store at low temperature | Store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.